v3.26.1
Divestitures (Tables)
 6 Months Ended
Jun. 30, 2026
Discontinued Operations and Disposal Groups [Abstract]  
Disposal Groups, Including Discontinued Operations
The following table summarizes the assets and liabilities of the Disposal Group that were classified as held for sale on the Unaudited Condensed Consolidated Balance Sheet as of June 30, 2026. As of December 31, 2025, the Company had no assets or liabilities related to divestiture activities that met the classification of held for sale.
June 30, 2026
Accounts receivable, net$2.4 
Inventories8.1 
   Intangible assets, net192.3 
     Assets held for sale$202.8 
Accounts payable$0.4 
Accrued and other current liabilities4.8 
Deferred tax liabilities20.5 
      Liabilities held for sale$25.7 
The following table summarizes the financial performance of Par Health for the three and six months ended June 27, 2025, which reflects the results of the Company’s former Generics business during this time period.
Major line items constituting income from discontinued operationsThree Months Ended
June 27, 2025		Six Months
Ended
June 27, 2025
Net sales$220.8 $433.5 
Cost of sales139.6 261.4 
Gross profit81.2 172.1 
Selling, general and administrative expenses32.5 66.5 
Research and development expenses5.6 10.8 
Combination, integration, and other related expenses2.6 2.6 
Operating income40.5 92.2 
Interest expense(0.2)(0.3)
Interest income2.1 3.8 
Other expense, net(0.7)(1.0)
Income from discontinued operations before income taxes41.7 94.7 
Provision for income taxes8.9 14.5 
Income from discontinued operations, net of tax (1)$32.8 $80.2 
(1) Results exclude income from discontinued operations, net of tax, of $0.1 million and $0.3 million for the three and six months ended June 27, 2025, respectively, related to the Company’s prior divestiture of its Nuclear Imaging business.